ILC Dover

Meet the soloPURE™ flexible aseptic isolator, a cost-effective closed-barrier system for sterile manufacturing that provides a closed Grade-A, aseptic environment for fill finish activities requiring positive and negative pressures.

With the growth of highly potent active pharmaceutical ingredients (HPAPIs) and multiple-use facilities that must protect against product cross contamination, the need for engineering controls to achieve high containment has become more critical.

Learn about the benefits of using a DoverPac® Powder Containment System

During this podcast we shall be discussing how sterile potent powders are becoming more common in the bio-pharmaceutical industry and the challenges around handling these powders in conventional aseptic containment systems. Review the overarching benefits of compliant. single use isolator systems when handling sterile products and how they mitigate the risk associated with potent product batch manufacture.

***Session 1: Thursday, April 22, 2021, 10am EDT, Session 2: Thursday, April 22, 2021, 11am EDT, Session 3: Thursday, April 22, 2021, 1pm EDT*** A drug’s journey from development to manufacturing to patients is paved with roadblocks and potholes; many threats can derail bio/pharmaceutical processes. Potential solutions to such pitfalls have been discussed for years; however, few manufacturers have embraced technology and process advances to proactively ensure drug supply chain continuity.

The COVID-19 pandemic should prompt bio/pharma facilities to assess how the potential spread of the virus may impact different areas of development and manufacturing facilities, employees, visitors, and product. Learn about strategies for evaluating practices at existing facilities and options for designing new facilities that can accommodate future needs, including flexibility requirements and any emerging threats. Live: Tuesday, May 26, 2020 at 2 pm EDT| 1pm CDT| 11am PDT On demand available after airing until May 26, 2021 Register free